ArticlePharmaceutical science advances2026
Fufang Huangbo Formula mitigates myeloproliferative neoplasms by activating p53/p21 signaling axis and inhibiting STAT3 and NF-κB signaling pathways.
Mingjie Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.